Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 10, 2009, 1:00AM ET - U.S. Markets open in 8 hours and 30 minutes. Dow Up 2.03% Nasdaq Up 1.97%
Orchid Cellmark Inc. (ORCH)On Nov 9: 1.67  Up 0.03 (1.83%)  
MORE ON ORCH
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Orchid Cellmark Inc.
1440 Chapin Avenue
Suite 310
Burlingame, CA 94010
United States - Map
Phone: 650-340-1888
Web Site: http://www.orchid.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Diagnostic Substances
Full Time Employees:427

BUSINESS SUMMARY 
Orchid Cellmark Inc., together with its subsidiaries, provides DNA testing services in the United States and the United Kingdom. Its services generate genetic profile information by analyzing an organism’s genetic identity. The company focuses on DNA testing primarily for human identity and agricultural applications. It offers forensic DNA, family relationship testing, government and private paternity testing, security, and immigration and other DNA testing services to government agencies, commercial companies, and private individuals. The company also provides agricultural DNA testing services for selective trait breeding; agricultural susceptibility testing to enable farmers to breed sheep resistant to degenerative diseases that affect the nervous systems of sheep and goats; and genetic marker analysis in animals to confirm relationships to members of the agricultural community. Orchid Cellmark was founded in 1995 and is headquartered in Burlingame, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Orchid Cellmark Inc.


    CORPORATE GOVERNANCE 
    Orchid Cellmark Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 37.4% of CGQ Universe companies and 16.4% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Thomas Bologna , 60
    Chief Exec. Officer, Pres and Exec. Director
    $ 560.00K $ 0
    Mr. James F. Smith CPA, 59
    Chief Financial Officer, Principal Accounting Officer and VP
    $ 246.00K $ 0
    Mr. William J. Thomas II, Esq, 49
    VP, Sec. and Gen. Counsel
    $ 245.00K $ 0
    Mr. Jeffrey S. Boschwitz Ph.D., 42
    VP of North America Marketing & Sales
    $ 141.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis